Thomas Garner

Insider Reports History

Entity
Individual
Location
2445 Technology Forest Blvd, 11 Th Floor, Spring, TX
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Garner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC EVP, Chief Commercial Officer Restricted Stock Units 45.4K $763K $16.81 Dec 9, 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Commercial Officer Restricted Stock Units 227K $239K $1.05 Feb 8, 2024 Direct
ACADIA PHARMACEUTICALS INC EVP, Chief Commercial Officer Stock Option (Right to Buy) 236K Dec 9, 2024 Direct
LEXICON PHARMACEUTICALS, INC. SVP, Chief Commercial Officer Stock Option (Right to Buy) 227K Feb 8, 2024 Direct

Insider Reports Filed by Thomas Garner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACAD ACADIA PHARMACEUTICALS INC Dec 9, 2024 2 $0 4 Dec 10, 2024 EVP, Chief Commercial Officer
ACAD ACADIA PHARMACEUTICALS INC Dec 9, 2024 0 $0 3 Dec 10, 2024 EVP, Chief Commercial Officer
LXRX LEXICON PHARMACEUTICALS, INC. Feb 8, 2024 2 $0 4 Feb 12, 2024 SVP, Chief Commercial Officer
LXRX LEXICON PHARMACEUTICALS, INC. Oct 9, 2023 1 $0 4 Oct 11, 2023 SVP, Chief Commercial Officer
LXRX LEXICON PHARMACEUTICALS, INC. Oct 9, 2023 0 $0 3 Oct 11, 2023 SVP, Chief Commercial Officer